Mild hypercholesterolemia, normal plasma triglycerides, and normal glucose levels across dementia staging in Alzheimer's disease: A clinical setting-based retrospective study

American Journal of Alzheimer's Disease and other Dementias

Volumn 26, Issue 5, 2011, Pages 399-405

  Ramdane, Said ^a   Daoudi Gueddah, Doria ^b  

^a Private Practice Office of Neurology   (Algeria)

^b UNIVERSITY OF SKIKDA   (Algeria)

Author keywords

Algeria; Alzheimer's disease; dementia staging; epidemiology; fasting plasma glucose; mild total hypercholesterolemia

Indexed keywords

CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEMENTIA; DISEASE SEVERITY; FEMALE; GERIATRIC PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 80054924950     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317511414552     Document Type: Article

References (36)

1. Nelson TJ, Alkon DL. Insulin and cholesterol pathways in neuronal function, memory and neurodegeneration. Biochem Soc Trans. 2005 ; 33: 1033-1036 (Pubitemid 41659107)
2. Kilander L, Boberg M, Lithell H. Peripheral glucose metabolism and insulin sensitivity in Alzheimer's disease. Acta Neurol Scand. 1993 ; 87 (4). 294-298 (Pubitemid 23122224)
3. Kuusisto J, Koivisto K, Mykkanen L, et al. Association between features of insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study. BMJ. 1997 ; 315 (7115). 1045-1049 (Pubitemid 27458392)
4. Peila R, Rodriguez BL, White LR, Launer LJ. Fasting insulin and incident dementia in an elderly population of Japanese-American men. Neurology. 2004 ; 63 (2). 228-233 (Pubitemid 38971119)
5. Diagnostic and Statistical Manual of Mental disorders. 3 rd ed. Washington, DC: American Psychiatric Association; 1987. Washington, DC: American Psychiatric Association ; 1987 :
6. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993 ; 43 (11). 2412-2414 (Pubitemid 23346995)
7. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology. 1984 ; 34 (7). 939-944 (Pubitemid 14076461)
8. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004 ; 110 (6). 227-239 (Pubitemid 38924592)
9. Notkola IL, Sulkava R, Pekkanen J, et al. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology. 1998 ; 17 (1). 14-20 (Pubitemid 28153361)
10. Evans RM, Emsley CL, Gao S, et al. Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population based study of African Americans. Neurology. 2000 ; 54 (1). 240-242 (Pubitemid 30038771)
11. Kivipelto M, Helkala EL, Laakso MP, et al. Apolipoprotein E epsilon 4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late Alzheimer disease. Ann Intern Med. 2002 ; 137 (3). 149-155 (Pubitemid 34827510)
12. Hall K, Murrell J, Ogunniyi A, et al. Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yuruba. Neurology. 2006 ; 66 (2). 223-227 (Pubitemid 43970158)
13. Solomon A, Kareholt I, Ngandu T, et al. Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology. 2007 ; 68 (10). 751-756 (Pubitemid 46667900)
14. Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA. Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord. 2009 ; 28 (1). 75-80
15. Launer LJ, With LR, Petrovitch H, Ross GW, Curb JD. Cholesterol and neuropathologic markers of AD: a population-based autopsy study. Neurology. 2001 ; 57 (8). 1447-1452 (Pubitemid 32995727)
16. Pappolla A, Bryant-Thomas TK, Herbert D, et al. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology. 2003 ; 61 (2). 199-205 (Pubitemid 36875301)
17. Lesser GT, Haroutunian V, Purohit DP, et al. Serum lipids are related to Alzheimer's pathology in nursing home residents. Dement Geriatr Cogn Disord. 2009 ; 27 (1). 42-49
18. Stewart R, With LR, Xue QL, Launer LJ. Twenty-six-year change in total cholesterol levels and incident dementia. The Honolulu-Asia Aging Study. Arch Neurol. 2007 ; 64 (1). 103-107 (Pubitemid 46072431)
19. Mielke MM, Zandi PP, Sjogren M, et al. High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology. 2005 ; 64 (10). 1689-1695 (Pubitemid 40695799)
20. Tan ZS, Seshadri S, Beiser A, et al. Plasma total cholesterol level as risk factor for Alzheimer disease. Arch Intern Med. 2003 ; 163 (9). 1053-1057 (Pubitemid 36548931)
21. Li G, Shofer JB, Kukull WA, et al. Serum cholesterol and risk of Alzheimer disease: a community-based cohort study. Neurology. 2005 ; 65 (7). 1045-1050 (Pubitemid 41429629)
22. Romas SN, Tang MX, Berlund L, Mayeux R. APOE genotype, plasma lipids, lipoproteins, and AD in community elderly. Neurology. 1999 ; 53 (3). 517-521 (Pubitemid 29382044)
23. Reitz C, Tang MX, Luchsinger JA, Mayeux R. Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol. 2004 ; 61 (5). 705-714 (Pubitemid 38637688)
24. Mielke MM, Zandi PP, Shao H, et al. 32-year relationship between cholesterol and dementia from midlife to late life. Neurology. 2010 ; 75 (21). 1888-1895
25. Reitz C, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA. Association of higher levels of high -density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol. 2010 ; 67 (12). 1491-1497
26. Caramelli P, Nitrini R, Maranhao R, et al. Increased apolipoprotein B serum concentration in Alzheimer's disease. Acta Neurol Scand. 1999 ; 100 (1). 61-63 (Pubitemid 29292552)
27. Czyzewski K, Lalowski MM, Pfeffer A, Barcikowska M. Lipid metabolism parameters in patients with Alzheimer's disease and their first degree relatives. Acta Neurobiol Experimentalis. 2001 ; 61 (1). 21-26 (Pubitemid 32187884)
28. Isbir T, Agachan B, Yilmaz H, et al. Apolipoprotein E gene polymorphism and lipid profiles in Alzheimer's disease. Am J Alzheimers Dis Other Dement. 2001 ; 16 (2). 77-81 (Pubitemid 32601692)
29. Mediene-Benchekor S, Brousseau T, Richard F, Benhamamouch S, Amouyel P. Blood lipid concentrations and risk of myocardial infarction. Lancet. 2001 ; 358 (9287). 1064-1065 (Pubitemid 32925131)
30. Boukli Hacene L, Meguenni K. Cardiovascular risk factors in Tlemcen (Algeria). Cahiers Santé. 2007 ; 17 (3). 153-158
31. Newschaffer CJ, Bush TL, Hale WE. Aging and total cholesterol levels: cohort, period, and survivorship effects. Am J Epidemiol. 1992 ; 136 (1). 23-34
32. Wilson PW, Anderson KM, Harris T, Kannel WB, Castelli WP. Determinants of change in total cholesterol and HDL-C with age: the Framingham study. J Gerontol. 1994 ; 49 (6). M252 - M257
33. Lamon-Fava S, Jenner JL, Jacques PF, Schaefer EJ. Effects of dietary intakes on plasma lipids, lipoproteins and apolipoproteins in free-living elderly men and women. Am J Clin Nutr. 1994 ; 59 (1). 32-41 (Pubitemid 24021705)
34. Abbott RD, Sharp DS, Burchfiel CM, et al. Cross-sectional and longitudinal changes in total and high density lipoprotein cholesterol levels over a 20-year period in elderly men: the Honolulu Heart Program. Ann Epidemiol. 1997 ; 7 (6). 417-424
35. Sabbagh M, Zahiri HR, Ceimo J, et al. Is there a characteristic lipid profile in Alzheimer's disease?. J Alzheimers Dis. 2004 ; 6 (6). 585-589 (Pubitemid 40164164)
36. Teunissen CE, Lutjohann D, von Bergman K, et al. Combination of serum markers related to several mechanisms in Alzheimer's disease. Neurobiol Aging. 2003 ; 24 (7). 893-902 (Pubitemid 36962973)